SYNERON MEDICAL LTD's ticker is ELOS and the CUSIP is M87245102. A total of 90 filers reported holding SYNERON MEDICAL LTD in Q1 2017. The put-call ratio across all filers is 0.03 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $2,360,000 | -5.7% | 215,559 | -9.1% | 2.13% | +5.0% |
| Q1 2017 | $2,503,000 | +235.5% | 237,217 | +167.2% | 2.03% | +188.2% |
| Q4 2016 | $746,000 | +17.3% | 88,777 | 0.0% | 0.70% | +11.9% |
| Q3 2016 | $636,000 | -6.9% | 88,777 | 0.0% | 0.63% | +13.9% |
| Q2 2016 | $683,000 | +5.2% | 88,777 | 0.0% | 0.55% | +101.1% |
| Q1 2016 | $649,000 | +111.4% | 88,777 | +123.1% | 0.28% | +183.5% |
| Q4 2015 | $307,000 | -35.6% | 39,792 | -40.3% | 0.10% | +40.6% |
| Q3 2015 | $477,000 | -45.9% | 66,644 | -19.7% | 0.07% | -32.4% |
| Q2 2015 | $881,000 | -26.8% | 82,977 | -14.6% | 0.10% | +56.9% |
| Q1 2015 | $1,203,000 | +32.6% | 97,192 | 0.0% | 0.06% | +44.4% |
| Q4 2014 | $907,000 | -13.5% | 97,192 | -7.1% | 0.04% | -18.2% |
| Q3 2014 | $1,048,000 | -17.8% | 104,614 | -15.3% | 0.06% | -9.8% |
| Q2 2014 | $1,275,000 | -57.1% | 123,544 | -48.3% | 0.06% | -54.5% |
| Q1 2014 | $2,975,000 | +1.2% | 238,923 | 0.0% | 0.13% | 0.0% |
| Q4 2013 | $2,939,000 | +42.7% | 238,923 | 0.0% | 0.13% | +59.5% |
| Q3 2013 | $2,060,000 | -6.2% | 238,923 | -5.3% | 0.08% | -20.8% |
| Q2 2013 | $2,195,000 | – | 252,306 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Acrospire Investment Management LLC | 2,738 | $30,000 | 90.91% |
| BRANDES INVESTMENT PARTNERS, LP | 2,901,971 | $31,921,000 | 0.65% |
| Lapides Asset Management, LLC | 186,200 | $2,044,000 | 0.42% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 51,703 | $569,000 | 0.04% |